Search bioRxiv⌕ Search

Biology subjects

Zaslona, Z.

Publications and source records attributed to Zaslona, Z..

2 recordsLinked to original sources

Mechanism of catalytic apparatus of human chitotriosidase-1 and its dual inactivation mode by the first-in-class OATD-01 inhibitor.

Despite extensive research over the past three decades, there are still uncertainties regarding the catalytic mechanism of human chitotriosidase-1. To fill the gap, we reanalysed the structural information available for this enzyme. Based on the existing and new experimental data, complemented by multi-scale simulations, we modelled the full-length structure of human chitotriosidase-1 and proposed the general model of its catalytic mechanism. We have elucidated the catalytic role of the four highly conserved structural motifs present in glycoside hydrolases 18 family and demonstrated the impact of ions on achieving optimal catalytic conditions. Furthermore, we have identified distinct mechanical motions within the catalytic domain that collectively facilitate the catalysis. Finally, we demonstrate how subtle dynamical changes observed within the active site upon binding of the OATD-01 inhibitor correspond to long-range effects that are transmitted across enzyme subunits, leading to profound biological consequences.

biophysics↗

Chitinase-1 inhibition reverses metabolic dysregulation and restores homeostasis in MASH animal models

OATD-01 is a chitinase-1 (CHIT1) inhibitor, reducing inflammation and fibrosis in animal models where chronic inflammation leads to tissue remodeling. CHIT1, predominantly secreted by macrophages, is overexpressed in metabolic-dysfunction-associated steatohepatitis (MASH). In this study, we demonstrated the efficacy of OATD-01 in two murine and a rat model of MASH. RNA-Seq analysis revealed that OATD-01 reversed MASH-dysregulated genes. Apart from the attenuation of inflammation and fibrosis, OATD-01 regulated metabolic processes such as lipid metabolism and glycolysis. We demonstrated that both genetic and pharmacological inactivation of CHIT1 resulted in inhibition of glycolysis and glucose uptake in primary macrophages. As a consequence, we observed increased ATP, lower citrate and increased acetate levels, resulting in a reduced IL-1{beta} secretion. These results revealed the key role for CHIT1 in regulating metabolism. OATD-01 is a macrophage modulator that can directly restore metabolic balance and consequently inhibit inflammation and fibrosis, supporting its use for MASH treatment.

pharmacology and toxicology↗